NEW YORK (GenomeWeb) – Roka Biosciences reported after the close of the market Friday that its fourth quarter revenues rose 7 percent from the fourth quarter of 2014.

For the three-month period ended Dec. 31, the molecular diagnostics firm reported revenues of $1.5 million compared to $1.4 million in the same period the year before.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.